This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Today's Health Winners and Losers

Shares of A.D.A.M. (ADAM) were among the worst-performing health-related stocks Tuesday, sliding 25% after the medical information company posted fourth-quarter results that disappointed investors.

The company reported a loss of $505,000, or 5 cents a share, on revenue of $2.5 million. Excluding items, the company earned $436,000, or 5 cents a share. During the year-earlier period, the company earned $676,000, or 7 cents a share, on revenue of $2.5 million. The company's latest results were hurt by a big rise in general and administrative expenses, which climbed to $1.3 million from $345,000 during the year-earlier period. Total operating costs and expenses rose to nearly $3 million during the fourth quarter, up from $1.8 million a year earlier. Shares were trading down $2.63 to $7.79.

Air Methods (AIRM - Get Report) shares rose 7% after the company swung to a fourth-quarter profit. The company, which provides air medical transportation services, earned $3.5 million, or 29 cents a share, reversing a year-earlier loss of $200,000, or 2 cents a share. The single-analyst forecast called for earnings of 20 cents a share. Revenue rose to $90.2 million from $68.3 million. Shares were rising $1.59 to $25.42.

Shares of inVentiv Health (VTIV), formerly called Ventiv Health, rose 6% after the provider of clinical services posted better-than-expected fourth-quarter results. The company reported earnings from continuing operations of $9.8 million, or 34 cents a share, on revenue of $175.3 million. Analysts expected earnings of 28 cents a share and revenue of $148.2 million. During the year-earlier quarter, the company earned $15.2 million, or 57 cents a share, on revenue of $117.4 million. Results during the year-earlier period included a tax benefit of $9.1 million, or 34 cents a share. Without the gain, the company would have earned $6.1 million, or 23 cents a share.

Looking ahead, inVentiv now sees 2006 earnings of $1.43 to $1.48 a share and revenue of $705 million to $725 million. Previously, the company projected earnings of $1.39 to $1.44 a share, with revenue of $685 million to $705 million. Analysts forecast earnings of $1.44 a share and revenue of $707.1 million. Shares were trading up $1.69 to $30.82.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs